Showing results (31-40 of 56) with videos related to

Sort By:
Pageof 6
Cancer|March 26, 2004
Strongyloidiasis in patients at a comprehensive cancer center in the United StatesAmar Safdar, Kumthorn Malathum, Saul J Rodriguez, et al.
Cancer|June 7, 2005
Bacterial infections in low-risk, febrile neutropenic patientsMallika Kamana, Carmelita Escalante, Craig A Mullen, et al.
The Journal of Antibiotics|December 3, 2015
In vitro activity of dalbavancin and five comparator agents against common and uncommon Gram-positive organisms isolated from cancer patientsKenneth V I Rolston, Weiqun Wang, Lior Nesher, et al.
Diagnostic Microbiology and Infectious Disease|October 3, 2003
In vitro antimicrobial activity of moxifloxacin compared to other quinolones against recent clinical bacterial isolates from hospitalized and community-based cancer patientsKenneth V I Rolston, Susan Frisbee-Hume, Barbara LeBlanc, et al.
Diagnostic Microbiology and Infectious Disease|November 30, 2002
Antimicrobial activity of a novel des-fluoro (6) quinolone, garenoxacin (BMS-284756), compared to other quinolones, against clinical isolates from cancer patientsKenneth V I Rolston, Susan Frisbee-Hume, Barbara M LeBlanc, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|January 28, 2006
The spectrum of Gram-positive bloodstream infections in patients with hematologic malignancies, and the in vitro activity of various quinolones against Gram-positive bacteria isolated from cancer patientsKenneth V I Rolston, Davood Yadegarynia, Dimitrios P Kontoyiannis, et al.
Infection|May 2, 2015
Ertapenem usage in cancer patients with and without neutropenia: a report on 97 cases from a comprehensive cancer centerL Nesher, F P Tverdek, S N Mahajan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 24, 2014
Development and validation of a clinical model to predict the presence of β-lactam resistance in viridans group streptococci causing bacteremia in neutropenic cancer patientsSamuel A Shelburne, Robert E Lasky, Pranoti Sahasrabhojane, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 27, 2013
Daptomycin use in neutropenic patients with documented gram-positive infectionsKenneth V I Rolston, Dina Besece, Kenneth C Lamp, et al.
Antimicrobial Agents and Chemotherapy|February 20, 2020
Activity of Cefiderocol and Comparators against Isolates from Cancer PatientsKenneth V I Rolston, Baghat Gerges, Samuel Shelburne, et al.
Pageof 6